Literature DB >> 17520679

IGF-I and mammographic density in four geographic locations: a pooled analysis.

Gertraud Maskarinec1, Yumie Takata, Zhao Chen, Inger Torhild Gram, Chisato Nagata, Ian Pagano, Kentaro Hayashi, Leslie Arendell, Guri Skeie, Sabina Rinaldi, Rudolph Kaaks.   

Abstract

Insulin-like growth factor (IGF-I) and prolactin have been found to be associated with breast cancer risk and with mammographic density. In a pooled analysis from 4 geographic locations, we investigated the association of percent mammographic density with serum levels of IGF-I, IGFBP-3 and prolactin. The pooled data set included 1,327 pre- and postmenopausal women: Caucasians from Norway, Arizona and Hawaii, Japanese from Hawaii and Japan, Latina from Arizona, and Native Hawaiians from Hawaii. Serum samples were assayed for IGF-I, IGFBP-3 and prolactin levels using ELISA assays. Mammographic density was quantified using a computer-assisted density method. After stratification by menopausal status, multiple regression models estimated the relation between serum analytes and breast density. All serum analytes except prolactin among postmenopausal women differed significantly by location/ethnicity group. Among premenopausal subjects, IGF-I levels and the molar ratio were highest in Hawaii, intermediate in Japan and lowest in Arizona. For IGFBP-3, the order was reversed. Among postmenopausal subjects, Norwegian women had the highest IGF-I levels and women in Arizona had the lowest while women in Japan and Hawaii had intermediate levels. We observed no significant relation between percent density and IGF-I or prolactin levels among pre-and postmenopausal women. The significant differences in IGF-I levels by location but not ethnicity suggest that environmental factors influence IGF-I levels, whereas percent breast density varies more according to ethnic background than by location. Based on this analysis, the influence of circulating levels of IGF-I, IGFBP-3, and prolactin on percent density appears to be very small. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17520679     DOI: 10.1002/ijc.22834

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.

Authors:  Margarethe Biong; Inger T Gram; Ilene Brill; Fredrik Johansen; Hiroko K Solvang; Grethe I G Alnaes; Toril Fagerheim; Yngve Bremnes; Stephen J Chanock; Laurie Burdett; Meredith Yeager; Giske Ursin; Vessela N Kristensen
Journal:  BMC Med Genomics       Date:  2010-03-19       Impact factor: 3.063

2.  Ethics and Community Involvement in Syntheses Concerning American Indian, Alaska Native, or Native Hawaiian Health: A Systematic Review.

Authors:  Matthew O Gribble; Deana M Around Him
Journal:  AJOB Empir Bioeth       Date:  2014-01-01

Review 3.  Prolactin and breast cancer etiology: an epidemiologic perspective.

Authors:  Shelley S Tworoger; Susan E Hankinson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-02       Impact factor: 2.673

4.  Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses' Health Studies.

Authors:  Megan S Rice; Shelley S Tworoger; Bernard A Rosner; Michael N Pollak; Susan E Hankinson; Rulla M Tamimi
Journal:  Breast Cancer Res Treat       Date:  2012-10-21       Impact factor: 4.872

5.  IGF1, IGFBP1, and IGFBP3 genes and mammographic density: the Multiethnic Cohort.

Authors:  Martijn Verheus; Gertraud Maskarinec; Christy G Woolcott; Christopher A Haiman; Loïc Le Marchand; Brian E Henderson; Iona Cheng; Laurence N Kolonel
Journal:  Int J Cancer       Date:  2010-09-01       Impact factor: 7.396

6.  Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II.

Authors:  Megan S Rice; Rulla M Tamimi; James L Connolly; Laura C Collins; Dejun Shen; Michael N Pollak; Bernard Rosner; Susan E Hankinson; Shelley S Tworoger
Journal:  Breast Cancer Res       Date:  2012-03-13       Impact factor: 6.466

7.  Immunoassay and Nb2 lymphoma bioassay prolactin levels and mammographic density in premenopausal and postmenopausal women the Nurses' Health Studies.

Authors:  Megan S Rice; Shelley S Tworoger; Kimberly A Bertrand; Susan E Hankinson; Bernard A Rosner; Yvonne B Feeney; Charles V Clevenger; Rulla M Tamimi
Journal:  Breast Cancer Res Treat       Date:  2014-12-13       Impact factor: 4.624

8.  Hormone and receptor activator of NF-κB (RANK) pathway gene expression in plasma and mammographic breast density in postmenopausal women.

Authors:  Rachel Mintz; Mei Wang; Shuai Xu; Graham A Colditz; Chris Markovic; Adetunji T Toriola
Journal:  Breast Cancer Res       Date:  2022-04-14       Impact factor: 6.466

9.  Body fatness during childhood and adolescence and breast density in young women: a prospective analysis.

Authors:  Kimberly A Bertrand; Heather J Baer; E John Orav; Catherine Klifa; John A Shepherd; Linda Van Horn; Linda Snetselaar; Victor J Stevens; Nola M Hylton; Joanne F Dorgan
Journal:  Breast Cancer Res       Date:  2015-07-16       Impact factor: 6.466

10.  Body size throughout the life course and mammographic density in Mexican women.

Authors:  Megan S Rice; Kimberly A Bertrand; Martin Lajous; Rulla M Tamimi; Gabriela Torres-Mejía; Carine Biessy; Ruy López-Ridaura; Isabelle Romieu
Journal:  Breast Cancer Res Treat       Date:  2013-03-05       Impact factor: 4.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.